Shopping Cart 0
Cart Subtotal
USD 0

Bausch & Lomb Inc - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Valeant Pharmaceuticals International Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It offers over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, lens care products, ophthalmic surgical devices and instruments. The company develops, manufactures and markets eye health products for the treatment of a wide range of eye conditions such as glaucoma, conjunctivitis, eye allergies, dry eye and retinal diseases. It has operations across the Americas, Europe, the Middle East, Africa and Asia-Pacific. Bausch & Lomb is headquartered in Bridgewater, New Jersey, the US.

Bausch & Lomb Inc-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Bausch & Lomb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Bausch & Lomb Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Bausch & Lomb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Bausch & Lomb Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Bausch & Lomb Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Bausch & Lomb Inc, Medical Equipment, Deal Details 11

Partnerships 11

Bausch & Lomb Enters Into Licensing Agreement With Cirle 11

Unilens Vision Sciences Amends Licensing Agreement With Bausch & Lomb 12

Bausch & Lomb Enters Into Distribution Agreement With PhysIOL For Hydrophilic Acrylic Intraocular Lenses 13

Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 14

Bausch & Lomb Enters Into Agreement With Cirle For Medical Technologies 15

Bausch & Lomb Enters Into Licensing Agreement With Paragon BioTeck For Phenylephrine 16

Equity Offering 17

Bausch & Lomb Withdraws IPO 17

Acquisition 19

Bausch & Lomb Acquires Doctor's Allergy Formula 19

Valeant Pharma Completes Acquisition Of Bausch & Lomb For USD 8.7 Billion 20

Bausch & Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For USD 631 Million 22

Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 24

Bausch & Lomb Inc-Key Competitors 26

Bausch & Lomb Inc-Key Employees 27

Bausch & Lomb Inc-Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Recent Developments 29

Strategy And Business Planning 29

Jul 24, 2018: Bausch + Lomb relocates company archive to new space in Rochester, NY Optics Center Facility, showcasing 165 years of science and innovation 29

Corporate Communications 30

Aug 20, 2018: Joseph Gordon Named U.S. President of Bausch + Lomb 30

Mar 30, 2017: Bausch + Lomb Announces U.S. Management Team Leadership 31

Government and Public Interest 33

Apr 19, 2018: Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE by ONE Program 33

Product News 34

Apr 27, 2018: Bausch + Lomb Will Present Scientific And Clinical Research During The Association For Research In Vision And Ophthalmology Meeting 34

Jun 20, 2017: Bausch + Lomb Unveils AMD Virtual Experience with State-of-the-Art Technology at Optometry's Meeting 36

May 10, 2017: Bausch + Lomb Reports Updated Results of the Antibiotic Resistance Monitoring in Ocular MicRoorganisms (ARMOR) Study 37

Jan 26, 2017: Bausch + Lomb Specialty Vision Products Introduces ScleralFil Solution for Scleral Lens Insertion 38

Other Significant Developments 39

Apr 19, 2018: Title Bausch + Lomb Reports More than two Million Used Contact Lens Materials Recycled Through ONE By ONE Program 39

Nov 15, 2017: Bausch + Lomb Helps To Recycle More Than One Million Units Of Contact Lens Materials Within First Year Of Launching The ONE By ONE Recycling Program 40

Jul 17, 2017: Bausch + Lomb Launches Innovative Contact Lens Patient Savings & Rewards Program 41

Apr 17, 2017: Bausch + Lomb ONE by ONE Recycling Program Reports Over 180,000 Units of Contact Lenses and Blister Packs Saved from Landfills Since Program Launch 42

Appendix 43

Methodology 43

About GlobalData 43

Contact Us 43

Disclaimer 43


List Of Figure

List of Figures

Bausch & Lomb Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Bausch & Lomb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Bausch & Lomb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Bausch & Lomb Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Bausch & Lomb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Bausch & Lomb Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Bausch & Lomb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Bausch & Lomb Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Bausch & Lomb Inc, Medical Equipment, Key Facts 2

Bausch & Lomb Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Bausch & Lomb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Bausch & Lomb Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Bausch & Lomb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Bausch & Lomb Inc, Deals By Market, 2012 to YTD 2018 9

Bausch & Lomb Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Bausch & Lomb Enters Into Licensing Agreement With Cirle 11

Unilens Vision Sciences Amends Licensing Agreement With Bausch & Lomb 12

Bausch & Lomb Enters Into Distribution Agreement With PhysIOL For Hydrophilic Acrylic Intraocular Lenses 13

Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 14

Bausch & Lomb Enters Into Agreement With Cirle For Medical Technologies 15

Bausch & Lomb Enters Into Licensing Agreement With Paragon BioTeck For Phenylephrine 16

Bausch & Lomb Withdraws IPO 17

Bausch & Lomb Acquires Doctor's Allergy Formula 19

Valeant Pharma Completes Acquisition Of Bausch & Lomb For USD 8.7 Billion 20

Bausch & Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For USD 631 Million 22

Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 24

Bausch & Lomb Inc, Key Competitors 26

Bausch & Lomb Inc, Key Employees 27

Bausch & Lomb Inc, Other Locations 28

Bausch & Lomb Inc, Subsidiaries 28

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Bausch & Lomb Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Summary

Bausch & Lomb Inc (Bausch & Lomb), a subsidiary of Valeant Pharmaceuticals International Inc, is a vision-care company with focus on the protection, enhancement and restoration of eyesight. It offers over-the-counter supplements, eye care products, contact lenses, ophthalmic pharmaceuticals, lens care products, ophthalmic surgical devices and instruments. The company develops, manufactures and markets eye health products for the treatment of a wide range of eye conditions such as glaucoma, conjunctivitis, eye allergies, dry eye and retinal diseases. It has operations across the Americas, Europe, the Middle East, Africa and Asia-Pacific. Bausch & Lomb is headquartered in Bridgewater, New Jersey, the US.

Bausch & Lomb Inc-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Bausch & Lomb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Bausch & Lomb Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Bausch & Lomb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Bausch & Lomb Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9

Bausch & Lomb Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Bausch & Lomb Inc, Medical Equipment, Deal Details 11

Partnerships 11

Bausch & Lomb Enters Into Licensing Agreement With Cirle 11

Unilens Vision Sciences Amends Licensing Agreement With Bausch & Lomb 12

Bausch & Lomb Enters Into Distribution Agreement With PhysIOL For Hydrophilic Acrylic Intraocular Lenses 13

Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 14

Bausch & Lomb Enters Into Agreement With Cirle For Medical Technologies 15

Bausch & Lomb Enters Into Licensing Agreement With Paragon BioTeck For Phenylephrine 16

Equity Offering 17

Bausch & Lomb Withdraws IPO 17

Acquisition 19

Bausch & Lomb Acquires Doctor's Allergy Formula 19

Valeant Pharma Completes Acquisition Of Bausch & Lomb For USD 8.7 Billion 20

Bausch & Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For USD 631 Million 22

Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 24

Bausch & Lomb Inc-Key Competitors 26

Bausch & Lomb Inc-Key Employees 27

Bausch & Lomb Inc-Locations And Subsidiaries 28

Head Office 28

Other Locations & Subsidiaries 28

Recent Developments 29

Strategy And Business Planning 29

Jul 24, 2018: Bausch + Lomb relocates company archive to new space in Rochester, NY Optics Center Facility, showcasing 165 years of science and innovation 29

Corporate Communications 30

Aug 20, 2018: Joseph Gordon Named U.S. President of Bausch + Lomb 30

Mar 30, 2017: Bausch + Lomb Announces U.S. Management Team Leadership 31

Government and Public Interest 33

Apr 19, 2018: Bausch + Lomb Reports More Than Two Million Used Contact Lens Materials Recycled Through ONE by ONE Program 33

Product News 34

Apr 27, 2018: Bausch + Lomb Will Present Scientific And Clinical Research During The Association For Research In Vision And Ophthalmology Meeting 34

Jun 20, 2017: Bausch + Lomb Unveils AMD Virtual Experience with State-of-the-Art Technology at Optometry's Meeting 36

May 10, 2017: Bausch + Lomb Reports Updated Results of the Antibiotic Resistance Monitoring in Ocular MicRoorganisms (ARMOR) Study 37

Jan 26, 2017: Bausch + Lomb Specialty Vision Products Introduces ScleralFil Solution for Scleral Lens Insertion 38

Other Significant Developments 39

Apr 19, 2018: Title Bausch + Lomb Reports More than two Million Used Contact Lens Materials Recycled Through ONE By ONE Program 39

Nov 15, 2017: Bausch + Lomb Helps To Recycle More Than One Million Units Of Contact Lens Materials Within First Year Of Launching The ONE By ONE Recycling Program 40

Jul 17, 2017: Bausch + Lomb Launches Innovative Contact Lens Patient Savings & Rewards Program 41

Apr 17, 2017: Bausch + Lomb ONE by ONE Recycling Program Reports Over 180,000 Units of Contact Lenses and Blister Packs Saved from Landfills Since Program Launch 42

Appendix 43

Methodology 43

About GlobalData 43

Contact Us 43

Disclaimer 43


List Of Figure

List of Figures

Bausch & Lomb Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Bausch & Lomb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Bausch & Lomb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Bausch & Lomb Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Bausch & Lomb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Bausch & Lomb Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7

Bausch & Lomb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Bausch & Lomb Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9


List Of Table

List of Tables

Bausch & Lomb Inc, Medical Equipment, Key Facts 2

Bausch & Lomb Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Bausch & Lomb Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6

Bausch & Lomb Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7

Bausch & Lomb Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8

Bausch & Lomb Inc, Deals By Market, 2012 to YTD 2018 9

Bausch & Lomb Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10

Bausch & Lomb Enters Into Licensing Agreement With Cirle 11

Unilens Vision Sciences Amends Licensing Agreement With Bausch & Lomb 12

Bausch & Lomb Enters Into Distribution Agreement With PhysIOL For Hydrophilic Acrylic Intraocular Lenses 13

Leica Microsystems Enters Into Distribution Agreement With Bausch & Lomb 14

Bausch & Lomb Enters Into Agreement With Cirle For Medical Technologies 15

Bausch & Lomb Enters Into Licensing Agreement With Paragon BioTeck For Phenylephrine 16

Bausch & Lomb Withdraws IPO 17

Bausch & Lomb Acquires Doctor's Allergy Formula 19

Valeant Pharma Completes Acquisition Of Bausch & Lomb For USD 8.7 Billion 20

Bausch & Lomb Completes Acquisition Of Remaining Stake In Technolas Perfect Vision From 20/10 Perfect Vision For USD 631 Million 22

Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 24

Bausch & Lomb Inc, Key Competitors 26

Bausch & Lomb Inc, Key Employees 27

Bausch & Lomb Inc, Other Locations 28

Bausch & Lomb Inc, Subsidiaries 28

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

Bausch & Lomb Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.